Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 01 - 05 tags : Collaboration save search
Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptides
Published: 2021-01-05 (Crawled : 16:00) - biospace.com/
SLP | News | $44.82 -1.19% -1.2% 82K
|
Technology Services
|
| O: 0.0%
H: 1.25%
C: 0.01%
collaboration
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin ProgramNew program demonstrates breadth of MInT platform with the inclusion of activating antibodies against integrin targets
Published: 2021-01-05 (Crawled : 15:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.16%
H: 1.61%
C: 1.34%
MORF | $27.9 0.18% 0.18% 460K
|
Health Technology
|
| O: -0.65%
H: 5.82%
C: -4.74%
collaboration research antibody
Leading Healthcare Services Organizations Collaborate to Provide Innovative COVID Therapy Access Model
Published: 2021-01-05 (Crawled : 13:03) - globenewswire.com
OPCH | $30.29 -3.29% -3.4% 1M
|
Health Services
|
| O: 0.0%
H: 3.05%
C: 0.57%
AMED | $91.04 -0.23% -0.23% 310K
|
Health Services
|
| O: 0.11%
H: 1.59%
C: 0.04%
covid therapy collaboration
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
Published: 2021-01-05 (Crawled : 13:01) - globenewswire.com
MORF | $27.9 0.18% 0.18% 460K
|
Health Technology
|
| O: -0.65%
H: 5.82%
C: -4.74%
collaboration research program
Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix’s Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection
Published: 2021-01-05 (Crawled : 12:03) - globenewswire.com
TNXP | $0.1581 5.47% 5.19% 2M
|
Health Technology
|
| O: 7.41%
H: 10.68%
C: 6.85%
collaboration research antibody tnx-3500 anti-cd40 kidney
Broadridge Collaborates with SLIB to Deliver Shareholder Rights Directive II Solution for French Market
Published: 2021-01-05 (Crawled : 08:07) - prnewswire.com
BR | $193.45 -0.08% -0.69% 420K
|
Commercial Services
|
| O: -0.5%
H: 1.14%
C: 0.64%
liver collaboration
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.